SCR Additional Information Pharmacy Survey - Pilot

Overview

Summary Care Records (SCR)

The SCR is an electronic record of important patient information, created from GP medical records. It can be seen and used by authorised staff involved in the patient's direct care.

The SCR holds important information about:

• Current medication
• Allergies and details of any previous bad reactions to medicines
• The name, address, date of birth and NHS number of the patient

Currently there are over 1.6 million patients who have chosen to add Additional Information to their SCR, with more than 18,000 patients providing consent for their Additional Information to be shared each week.

If present in the GP health record SCRs with Additional Information can contain the following:

• Significant medical history and procedures (past and present)
• Reason for medication
• Anticipatory care information (such as information about the management of long term conditions) 
• Communication preferences (as per the SCCI1605 Accessible information national dataset)
• End of life care information (as per the SCCI1580 Palliative Care Co-ordination national dataset)
• Immunisations 
• Contact details for family, carers and healthcare professionals

Why your views matter

The purpose of this survey is to assess the benefits and/or disadvantages of the Additional Information for Pharmacy staff who view Summary Care Records.

What happens next

In line with the provisions of the government’s Code of Practice on Consultations (available at https://www.gov.uk/government/publications/consultation-principles-guidance), a summary report will be published within 12 weeks of the survey closing. Publication may be on this website, elsewhere online and/or in printed form. Within three months of a survey ending we aim to publish a summary of responses received and provide a link to it from this page. This may include quotes of comments, which however, will be non-attributable.

If appropriate, the summary will include a list of organisations that responded but not personal names, addresses or other contact details.

Note that unless we have asked for consent to contact you to discuss feedback, and you have provided that consent, we will not respond to comments on an individual basis.